Orthobiologics & Regenerative Medicine Series: The Basics of Regenerative Medicine presented by Allison Bean, MD, PhD-The Basics of Regenerative Medicine

Video Transcription

Video Summary

Dr. Allison Bean, an assistant professor at the University of Pittsburgh Medical Center, gave a presentation on orthobiologics and regenerative medicine. She discussed the current state of clinical applications for these therapies and highlighted the need for more research to fully understand their efficacy and mechanisms of action. Dr. Bean explained that while stem cells and orthobiologics show promise for tissue regeneration, they are not currently FDA approved for orthopedic use. She emphasized the importance of evidence-based practice and urged clinicians to be honest with their patients about the limitations of these treatments. Dr. Bean also discussed several orthobiologic products, including platelet-rich plasma, bone marrow aspirate concentrate, and microfragmented adipose tissue. She explained their preparation methods, mechanisms of action, and current FDA approvals or lack thereof. Dr. Bean highlighted the need for standardized preparation methods and larger clinical studies to better understand the effectiveness of these therapies. She also cautioned against overstating the capabilities of orthobiologics and the potential risks of unregulated treatments. Dr. Bean concluded by encouraging clinicians to stay informed, involve patients in shared decision-making, and advocate for evidence-based practice in the field of regenerative medicine.

Keywords

orthobiologics

regenerative medicine

clinical applications

evidence-based practice

tissue regeneration

FDA approved

preparation methods

mechanisms of action

effectiveness

risks